Dandekar Atul bought MAZE

May 4, 2026 · Form 4 insider transaction

Dandekar Atul bought 8,320 shares of Maze Therapeutics, Inc. at $10.42 per share, a transaction worth $86.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.